Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	5.28	118.18	112.25
Graham Fair Price	-2.64	27.94	28.70
PEG	-138.04	-1.49	-0.63
Price/Book	1.19	1.87	1.85
Price/Cash Flow	24.04	10.79	8.70
Prices/Earnings	8.67	9.71	8.93
Price/Sales	-16.63	4.45	5.34
Price/FCF	24.04	10.79	8.70
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	300.45	0.67	0.17
Operating Margin	78.56	0.36	0.20
ROA	-4.54	< 0.005	< 0.005
ROE	0.05	0.05	-6.88
ROIC	< 0.005	0.02	125.09
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.01	< 0.005	-672.53
Dividends QOQ	< 0.005	< 0.005	76.64
EBIT QOQ	-0.11	1.19	1022.48
EPS QOQ	-0.14	-0.07	54.35
FCF QOQ	0.14	-0.18	28.64
Revenue QOQ	0.02	0.22	1117.56
Naive Interpretation	member

03 - Financial Growth · Best

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	151.60	0.00	inf
Days Sales Outstanding (DSO)	1475.19	1189.36	-19.38
Inventory Turnover	0.59	0.00	inf
Debt/Capitalization	0.86	0.86	-0.33
Quick Ratio	0.00	0.00	0.00
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	26.59	26.82	0.89
Cash	12.28	15.65	27.39
Capex	0.00	0.00	0.00
Free Cash Flow	5.66	4.66	-17.69
Revenue	9.22	11.29	22.46
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.00	0.00	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	85.45	88.68	3.78
Naive Interpretation	Member

06 - Financial Health · Bad

Rating